- Home
- BRN vs ERNA Comparison
BRN vs ERNA Comparison
Compare BRN & ERNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRN
- ERNA
- Stock Information
- Founded
- BRN 1956
- ERNA 2018
- Country
- BRN United States
- ERNA United States
- Employees
- BRN N/A
- ERNA N/A
- Industry
- BRN Oil & Gas Production
- ERNA Biotechnology: Pharmaceutical Preparations
- Sector
- BRN Energy
- ERNA Health Care
- Exchange
- BRN Nasdaq
- ERNA Nasdaq
- Market Cap
- BRN 12.2M
- ERNA 10.2M
- IPO Year
- BRN N/A
- ERNA N/A
- Fundamental
- Price
- BRN $1.16
- ERNA $1.36
- Analyst Decision
- BRN
- ERNA
- Analyst Count
- BRN 0
- ERNA 0
- Target Price
- BRN N/A
- ERNA N/A
- AVG Volume (30 Days)
- BRN 23.9K
- ERNA 252.3K
- Earning Date
- BRN 12-15-2025
- ERNA 11-07-2025
- Dividend Yield
- BRN N/A
- ERNA N/A
- EPS Growth
- BRN N/A
- ERNA N/A
- EPS
- BRN N/A
- ERNA N/A
- Revenue
- BRN $18,073,000.00
- ERNA $1,000.00
- Revenue This Year
- BRN N/A
- ERNA N/A
- Revenue Next Year
- BRN N/A
- ERNA N/A
- P/E Ratio
- BRN N/A
- ERNA N/A
- Revenue Growth
- BRN N/A
- ERNA N/A
- 52 Week Low
- BRN $1.08
- ERNA $1.09
- 52 Week High
- BRN $2.28
- ERNA $14.40
- Technical
- Relative Strength Index (RSI)
- BRN 49.78
- ERNA 45.19
- Support Level
- BRN $1.09
- ERNA $1.23
- Resistance Level
- BRN $1.21
- ERNA $1.84
- Average True Range (ATR)
- BRN 0.05
- ERNA 0.10
- MACD
- BRN 0.00
- ERNA -0.04
- Stochastic Oscillator
- BRN 62.54
- ERNA 24.24
About BRN Barnwell Industries Inc.
Barnwell Industries Inc is an oil and gas firm. Its areas of operations include acquiring, developing, producing, and selling oil and natural gas. The company acquires and develops crude oil and natural gas assets. The company's operating segment includes Oil and natural gas, Contract drilling, Land investment, and Others. It generates maximum revenue from the Oil and natural gas segment. It operates in two geographical segments the United States, which generates a majority of revenue, and Canada.
About ERNA Eterna Therapeutics Inc.
Ernexa Therapeutics Inc is a biotechnology company. The company develops transformational new medicines using various cell engineering technologies for cancer and autoimmune diseases. The proprietary technology of the company transforms induced pluripotent stem cells (iPSCs) into induced mesenchymal stem cells (iMSCs), offering potential off-the-shelf treatment solutions without the need for patient-specific cell harvesting.